Clinical Trials Logo

Clinical Trial Summary

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, which on the one hand reduces the accident rate of wheelchair and on the other hand and facilitates the access to the wheelchair to people who cannot claim it without the use of a safety device of this type. The robotic assistance module is programmed to detect positive and negative obstacles.


Clinical Trial Description

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type. The robotic assistance module is program to detect positive and negative obstacles. This study "SWADAPT3" follows "SWADAPT1" and "SWADAPT2" with patients with Neurological Disorders, Regular Drivers of Electric Wheelchairs, in the same conditions: Each patient included tested a wheelchair equipped with a collision avoidance assistance module in 2 conditions, assistance activated or not. This evaluation was carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient performed the circuit 6 times, including 3 with activated assistance, in a random order established upstream. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05459779
Study type Interventional
Source Pôle Saint Hélier
Contact
Status Completed
Phase N/A
Start date July 8, 2022
Completion date July 12, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4
Completed NCT06278025 - Dysphagia and Deep Cervical Flexor Muscles
Completed NCT03300856 - Chart Review: Central Motor Conduction Time in Neurological Disorders
Recruiting NCT06219200 - Automatic Voice Analysis for Dysphagia Screening in Neurological Patients
Recruiting NCT05106725 - Wearable Devices and Biomarkers Project (Healthiomics)
Completed NCT04119297 - Effects of Cold Application and Heparinoid on Periorbital Edema and Ecchymosis N/A
Completed NCT03490539 - Disease-Modifying Treatments for Myasthenia Gravis
Recruiting NCT05425186 - A Reliability and Validity Study: Urdu Version of Rivermead Extended Activities of Daily Life
Completed NCT03890965 - Effects of the Application of a Reflex Locomotion Program in the Neurological Hand N/A
Not yet recruiting NCT05363085 - The Cerebral-Respiratory Interaction in Controlled Mechanically Ventilated Neurosurgical Patients. (The CeRes-CMV Study)
Recruiting NCT03699514 - Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
Completed NCT04820153 - Monitoring Physical Activity in Hispanic Women With Chronic Neurological Disorders N/A
Completed NCT03639909 - Analysis of the Sweat Response According to the Pathology in Neurologic Patients
Completed NCT05350839 - Reliability and Validity of HHIRS General Quality of Life Questionnaire
Completed NCT04934085 - COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education
Recruiting NCT06072287 - The Living With a Long-Term Condition Study
Recruiting NCT04436068 - Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging N/A
Completed NCT04259151 - Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving N/A
Completed NCT03606668 - Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders N/A
Recruiting NCT05361707 - Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances Phase 3